Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Greco

Showing results (311-320 of 313) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 313 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulationF M Muggia, J D Hainsworth, S Jeffers, et al.
American Journal of Clinical Oncology|October 22, 1998
Sequential treatment including high-dose chemotherapy with peripheral blood stem cell support in patients with high-risk stage II-III breast cancer: outpatient administration in community cancer centersL S Schwartzberg, R Birch, W H West, et al.
British Journal of Cancer|March 10, 2001
Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancerP Thirion, P Piedbois, M Buyse, et al.
Pageof 32

Showing results (311-320 of 313) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 313 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulationF M Muggia, J D Hainsworth, S Jeffers, et al.
American Journal of Clinical Oncology|October 22, 1998
Sequential treatment including high-dose chemotherapy with peripheral blood stem cell support in patients with high-risk stage II-III breast cancer: outpatient administration in community cancer centersL S Schwartzberg, R Birch, W H West, et al.
British Journal of Cancer|March 10, 2001
Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancerP Thirion, P Piedbois, M Buyse, et al.
Pageof 32